Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (2)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1199)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (161)
Global (1)
South-East Asia (12)
Western Pacific (39)
Diseases
COVID-19 (1599)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (53)
Pertussis (122)
Pneumococcal disease (310)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (14)
Moderate (9)
Low (132)
Critically low (732)
Not applicable (312)
1599 results found
2026
COVID-19 vaccination in 2026 and 2027
2026
∙
Haute Autorité de Santé
COVID-19 vaccination strategy: revision of the place of the NUVAXOVID vaccine
2025
∙
Dhayfule, D. Wu, Y. H. Ashyani, A. Li, M. C. Tsai, C. S. Chen, P. L. Nordling, T.
A meta-analysis of vaccine efficacy from phase III clinical trials of approved vaccines against SARS-CoV-2 and variants
2025
∙
Ndzouboukou, J. L. B. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy Adults
2025
∙
Banga Ndzouboukou, J. L. Kamara, A. A. Ullah, N. Lei, Q. Fan, X. L.
A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults
2025
∙
Green, R. Marjenberg, Z. Lip, G. Y. H. Banerjee, A. Wisnivesky, J. Delaney, B. C. Peluso, M. J. Wynberg, E. Abduljawad, S.
A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID
2025
∙
Alshareefi, A. H. Zaid, M. H. Hamdi, H. A. Zaylaee, S. Y. Muthaffar, I. Y. Salim, A. M. Aqeely, E. A. Alaqi, S. M. Madkhali, H. A. Hedari, G. F. Hadadi, R. A. Shajeri, S. M. Harjah, M. A.
A Systematic Review of COVID-19 Vaccination Side Effects, Acceptance, and Attitudes Among Healthcare Workers in Saudi Arabia
2025
∙
Hinzpeter, E. L. Kairies-Schwarz, N. Beaudart, C. Douxfils, J. Nayak, D. Hiligsmann, M.
A Systematic Review of Discrete Choice Experiments on Preferences for COVID-19 Vaccinations
2025
∙
Qi, X.
A systematic review of global COVID-19 vaccine PPPs: drivers and barriers to governance alignment
2025
∙
Ebrahimi, B. Kargar Jahromi, H. Shafiei Jahromi, N. Molayem, M.
A Systematic Review of Ocular Complications Following Different Types of Covid-19 Vaccines
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register